• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用不同重结晶方法对曲格列酮原料药进行固态变异研究。

Solid-state variation of troglitazone drug substance by using a different recrystallization method.

作者信息

Suzuki Nobuyuki, Kasahara Ko, Watanabe Yoshiaki, Kinoshita Suzue, Hasegawa Hirokazu, Kawasaki Takao

机构信息

Product Development Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan.

出版信息

Drug Dev Ind Pharm. 2003 Aug;29(7):805-12. doi: 10.1081/ddc-120021780.

DOI:10.1081/ddc-120021780
PMID:12906338
Abstract

Rapid and slow crystallization methods (A and B) were applied for troglitazone, an equal mixture of four stereoisomers. Differences in the powder x-ray diffractometry patterns and hygroscopic patterns were observed among the samples crystallized by these methods, suggesting that troglitazone has solid-state variation. In this article, troglitazone recrystallized by method A was evaluated to clarify its structural characteristics and physical property. The crystal structure of predried troglitazone recrystallized by method A was proved to be a dihydrate. By drying, it changed reversibly to an anhydrate, which is the same structure as the RS/SR form, keeping the same enantiomer ratio. The solubility of the troglitazone by method A higher than that by method B at all enantiomer levels. But making the troglitazone amorphous equalized the enantiomeric solubilities of the substances by both methods as well as increased the intrinsic solubilities. Troglitazone by both methods was proved to be stable and retained the ratio of the stereoisomers.

摘要

快速和慢速结晶方法(A和B)应用于曲格列酮,它是四种立体异构体的等量混合物。通过这些方法结晶的样品之间观察到粉末X射线衍射图谱和吸湿图谱存在差异,这表明曲格列酮存在固态变化。在本文中,对通过方法A重结晶的曲格列酮进行了评估,以阐明其结构特征和物理性质。通过方法A重结晶的预干燥曲格列酮的晶体结构被证明是二水合物。通过干燥,它可逆地转变为无水合物,其结构与RS/SR形式相同,保持相同的对映体比例。在所有对映体水平上,通过方法A得到的曲格列酮的溶解度高于通过方法B得到的。但是将曲格列酮制成无定形会使两种方法得到的物质的对映体溶解度相等,同时也增加了固有溶解度。两种方法得到的曲格列酮都被证明是稳定的,并且保留了立体异构体的比例。

相似文献

1
Solid-state variation of troglitazone drug substance by using a different recrystallization method.采用不同重结晶方法对曲格列酮原料药进行固态变异研究。
Drug Dev Ind Pharm. 2003 Aug;29(7):805-12. doi: 10.1081/ddc-120021780.
2
Physical property of troglitazone, an equal mixture of four stereoisomers.曲格列酮的物理性质,四种立体异构体的等量混合物。
Int J Pharm. 2002 Nov 6;248(1-2):71-80. doi: 10.1016/s0378-5173(02)00430-1.
3
Evaluation of solid state form of troglitazone by solid state NMR spectroscopy.通过固态核磁共振光谱法评估曲格列酮的固态形式。
J Pharm Biomed Anal. 2005 Feb 7;37(1):177-81. doi: 10.1016/j.jpba.2004.09.035.
4
Physicochemical and crystal structure analyses of the antidiabetic agent troglitazone.抗糖尿病药物曲格列酮的物理化学和晶体结构分析。
Chem Pharm Bull (Tokyo). 2003 Jul;51(7):807-14. doi: 10.1248/cpb.51.807.
5
Evaluation of solid dispersions on a molecular level by the Raman mapping technique.通过拉曼映射技术在分子水平上评估固体分散体。
Int J Pharm. 2008 Sep 1;361(1-2):12-8. doi: 10.1016/j.ijpharm.2008.05.009. Epub 2008 May 16.
6
Do amorphous troglitazones prepared from two diastereomer-pairs have the same molecular mobility and crystallization rate at the surface?由两对非对映异构体制备的无定形曲格列酮在表面具有相同的分子迁移率和结晶速率吗?
Chem Pharm Bull (Tokyo). 2011;59(12):1452-7. doi: 10.1248/cpb.59.1452.
7
Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR.通过固态 NMR 预测曲格列酮/聚乙烯吡咯烷酮固体分散体的再结晶行为。
Int J Pharm. 2010 Jan 4;383(1-2):18-23. doi: 10.1016/j.ijpharm.2009.08.037. Epub 2009 Sep 2.
8
Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method.物理混合物中的含水量和加热温度对采用密闭熔融法制备的曲格列酮 - PVP K30固体分散体结晶度的影响。
Int J Pharm. 2005 Sep 30;302(1-2):103-12. doi: 10.1016/j.ijpharm.2005.06.021.
9
Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.曲格列酮晶体物理性质对加热过程中与聚乙烯吡咯烷酮分子相互作用的影响。
Int J Pharm. 2007 May 4;336(1):82-9. doi: 10.1016/j.ijpharm.2006.11.041. Epub 2006 Nov 26.
10
Crystal structure of an antidiabetic agent, (+/-)-5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, troglitazone dihydrate.抗糖尿病药物(±)-5-[4-(6-羟基-2,5,7,8-四甲基色满-2-基甲氧基)苄基]-2,4-二氧代噻唑烷二水合物曲格列酮的晶体结构
Anal Sci. 2001 Mar;17(3):467-8. doi: 10.2116/analsci.17.467.